Joint Formulary & PAD

Guideline Profile : Attention Deficit Hyperactivity Disorder (ADHD) - Children 6-17yrs

Committee Recommendations (2)

02 Feb 26 - Not Set

A Teamnet page for information and guidance has been created to support practices when dealing with patients who wish to exercise their legal right to choose a provider for an ADHD or Autism Spectrum Disorder assessment.

You can access this Team net page gere: Right To Choose - ADHD & Autism

14 Jan 26 - Not Set

The prescribing of drugs for ADHD in children and young people is supported by shared care agreements.

There are TWO shared care agreements for each drug. One for prescribers operating under the Locally Commissioned Service (LCS) and one for non-LCS.

Guideline Profile

Indication :
Attention Deficit Hyperactivity Disorder (ADHD) - Children 6-17yrs
Keywords :
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Supporting Documents :
11